Los puntos clave no están disponibles para este artículo en este momento.
In this review we aim to address the current status of phage therapy in the management of multidrug-resistant infections, from compassionate use cases to ongoing clinical trials, as well as the challenges this approach presents in the particular context of CF patients.
Cocorullo et al. (Fri,) studied this question.